The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

FC Arnett, SM Edworthy, DA Bloch… - … : Official Journal of …, 1988 - Wiley Online Library
FC Arnett, SM Edworthy, DA Bloch, DJ Mcshane, JF Fries, NS Cooper, LA Healey…
Arthritis & Rheumatism: Official Journal of the American College …, 1988Wiley Online Library
The revised criteria for the classification of rheumatoid arthritis (RA) were formulated from a
computerized analysis of 262 contemporary, consecutively studied patients with RA and 262
control subjects with rheumatic diseases other than RA (non‐RA). The new criteria are as
follows: 1) morning stiffness in and around joints lasting at least 1 hour before maximal
improvement; 2) soft tissue swelling (arthritis) of 3 or more joint areas observed by a
physician; 3) swelling (arthritis) of the proximal interphalangeal, metacarpophalangeal, or …
Abstract
The revised criteria for the classification of rheumatoid arthritis (RA) were formulated from a computerized analysis of 262 contemporary, consecutively studied patients with RA and 262 control subjects with rheumatic diseases other than RA (non‐RA). The new criteria are as follows: 1) morning stiffness in and around joints lasting at least 1 hour before maximal improvement; 2) soft tissue swelling (arthritis) of 3 or more joint areas observed by a physician; 3) swelling (arthritis) of the proximal interphalangeal, metacarpophalangeal, or wrist joints; 4) symmetric swelling (arthritis); 5) rheumatoid nodules; 6) the presence of rheumatoid factor; and 7) radiographic erosions and/or periarticular osteopenia in hand and/or wrist joints. Criteria 1 through 4 must have been present for at least 6 weeks. Rheumatoid arthritis is defined by the presence of 4 or more criteria, and no further qualifications (classic, definite, or probable) or list of exclusions are required. In addition, a “classification tree” schema is presented which performs equally as well as the traditional (4 of 7) format. The new criteria demonstrated 91–94% sensitivity and 89% specificity for RA when compared with non‐RA rheumatic disease control subjects.
Wiley Online Library